Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Phase II CALAVI trials of Calquence in COVID-19 do not meet primary efficacy endpoint

Nov. 16, 2020

RNA drugging strategies beyond oligos shaping up

Nov. 16, 2020

Zydus reports positive phase II data for PegiHep in patients with COVID-19 in India

Nov. 16, 2020

Trinomab cleared to begin phase I study in Australia with anti-tetanus toxin monoclonal antibody

Nov. 13, 2020

Verrica reports phase II topline data on VP-102 for external genital warts

Nov. 13, 2020

Selva begins phase I study with SLV-213 to treat COVID-19

Nov. 13, 2020

BVX-0320 vaccine candidate shows promising preclinical efficacy against SARS-CoV-2

Nov. 13, 2020

Shanghai Public Utilities Institute patents antibodies for SARS-CoV-2 infection

Nov. 13, 2020

Enrollment completed in phase III study of Covishield in India

Nov. 13, 2020

Sorrento files IND for phase I study of intranasal COVI-DROPS

Nov. 12, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.